# Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets

> **NCT01217190** · PHASE1,PHASE2 · COMPLETED · sponsor: **MonoSol Rx** · enrollment: 48 (actual)

## Conditions studied

- Nausea and Vomiting, Postoperative
- Nausea With Vomiting Chemotherapy-Induced

## Interventions

- **DRUG:** Ondansetron (ODFS)
- **DRUG:** Zofran (ODT)

## Key facts

- **NCT ID:** NCT01217190
- **Lead sponsor:** MonoSol Rx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09-16
- **Primary completion:** 2008-09-26
- **Final completion:** 2008-10-06
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01217190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01217190, "Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01217190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*